|1.||Marien, Marc: 1 article (12/2009)|
|2.||Blin, Olivier: 1 article (12/2009)|
|3.||Casse-Perrot, Catherine: 1 article (12/2009)|
|4.||Kaladjian, Arthur: 1 article (12/2009)|
|5.||Tisne-Versailles, Jacky: 1 article (12/2009)|
|6.||Chopin, Philippe: 1 article (12/2009)|
|7.||Micallef, Joelle: 1 article (12/2009)|
|8.||Audebert, Christine: 1 article (12/2009)|
|9.||Sokoloff, Pierre: 1 article (12/2009)|
|10.||Pitel, Séverine: 1 article (12/2009)|
|1.||Memory Disorders (Memory Loss)
12/01/2009 - "These results indicate that DMAE p-Glu reduces the deleterious effect of scopolamine on long-term memory in healthy volunteers and suggest that DMAE p-Glu might be effective in reducing memory deficits in patients with cognitive impairment."
12/01/2009 - "Clinical study results show that scopolamine induced a memory deficit and that DMAE p-Glu produced a significant positive effect on scores in the Buschke test, as well as a slight but significant difference on choice reaction time. "
12/01/2009 - "In rat experiments, DMAE p-Glu increased the extracellular levels of choline and acetylcholine in the medial prefrontal cortex, as assessed by intracerebral microdialysis, improved performance in a test of spatial memory, and reduced scopolamine-induced memory deficit in passive avoidance behavior. "
12/01/2009 - "Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies."
|2.||Choline (Choline Chloride)
|3.||Acetylcholine (Acetylcholine Chloride)